Remedy Pharmaceuticals, Inc. Email Format

Pharmaceutical ManufacturingNew York, United States2-10 Employees

Remedy Pharmaceuticals, Inc. is a small specialty pharmaceutical company based in New York City, focused on late-stage therapies for life-threatening brain edema-related conditions where current approved treatments are inadequate or absent. Central nervous system-related edema presents a significant unmet medical need, linked with high mortality and morbidity across critical care settings and chronic brain diseases. The company aims to improve patient management in this space by advancing therapies capable of addressing edema.

Remedy’s portfolio work centers on CIRARA, an intravenous glyburide formulation studied for large hemispheric infarction, with efficacy data from Phase 2 and Phase 3 trials presented at the International Stroke Conference in 2025. This activity situates Remedy within the specialty pharma landscape as a late-stage, CNS-focused developer pursuing treatments for severe brain injuries and related conditions. The organization operates with a small team, underscoring its focused, research-driven approach.

Get verified Remedy Pharmaceuticals, Inc. emails free

Company overview Employee directory